Inhaled nitric oxide in the term newborn.
Inhaled nitric oxide is a selective pulmonary vasodilator that serves integral diagnostic and therapeutic roles in the clinical management of near-term and term newborns with hypoxemic respiratory failure and pulmonary hypertension. Its proper use and potential limitations in current clinical practice are reviewed.
Kinsella
John P
JP
The Children's Hospital and the University of Colorado School of Medicine, Aurora, CO 80045, USA. John.Kinsella@uchsc.edu
D000280:Administration, Inhalation; D002986:Clinical Trials as Topic; D004452:Echocardiography; D015199:Extracorporeal Membrane Oxygenation; D006801:Humans; D007231:Infant, Newborn; D009569:Nitric Oxide / Q000008:administration & dosage*; D010547:Persistent Fetal Circulation Syndrome / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000008:administration & dosage*
D014665:Vasodilator Agents; D009569:Nitric Oxide